| abstract |
The present invention discloses a class of a compound shown by general formula (I), a pharmaceutically acceptable salt thereof, an easily hydrolyzed prodrug ester or an isomer thereof, a pharmaceutical composition containing this class of compounds as an inhibitor of sodium-glucose cotransporter 2 (SGLT2), for treating or delaying diabetes, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, insulin resistance, hyperglycemia, hyperinsulinemia, rising fatty acid or glycerin, hyperlipidemia, obesity, hypertriglyceridemia, X syndrome, diabetic complication, atherosclerosis or hypertension etc. and related diseases. |